ORGANIC FOOD PRODUCTS
                        1,200,000 Shares


                     UNDERWRITING AGREEMENT



                                            _______________, 1997



Sentra Securities Corporation
Spelman & Co., Inc.
2355 Northside Drive, Suite 200
San Diego, CA  92108
(As Representatives of the Several 
Underwriters Named in Schedule 1 hereto)

Dear Sirs:

     Organic Food Products, a California corporation (the "Company"), hereby 
confirms its agreement (this "Agreement") with the several underwriters named 
in Schedule 1 hereto (the "Underwriters"), for whom Sentra Securities 
Corporation and Spelman & Co., Inc.  have been duly authorized to act as 
representatives (in such capacity, the "Representatives"), as set forth below:

                                  SECTION 1.
                         DESCRIPTION OF TRANSACTION

     The Company proposes to issue and sell to the Underwriters on the 
Closing Date (as defined below), pursuant to the terms and conditions of this 
Agreement, an aggregate of 1,200,000 shares ("Firm  Shares") of the Company's 
Common Stock ("Common Stock") at a price of $5.00 per Share on the terms as 
hereinafter set forth.  The Company also proposes to issue and sell to the 
several Underwriters on or after the Closing Date not more than 180,000 
additional Shares if requested by the Representatives as provided in Section 
3.02 of this Agreement (the "Option Shares").  The Firm Shares and any Option 
Shares are collectively referred to herein as the "Shares."

                                  SECTION 2.
               REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     In order to induce the Underwriters to enter into this Agreement, the 
Company hereby represents and warrants to and agrees with the Underwriters 
that:



          2.1  REGISTRATION STATEMENT AND PROSPECTUS.  A registration statement
on Form SB-2  (File No. _______) with respect to the Shares, including the 
related prospectus, copies of which have heretofore been delivered by the 
Company to the Underwriters, has been filed by the Company in conformity with 
the requirements of the Securities and Exchange Commission (the "Commission") 
under the Securities Act of 1933, as amended (the "Act"), and one or more 
amendments to such registration statement have been so filed.  After the 
execution of this Agreement, the Company will file with the Commission either 
(a) if such registration statement, as it may have been amended, has been 
declared by the Commission to be effective under the Act, a prospectus in the 
form most recently included in an amendment to such registration statement 
(or, if no such amendment shall have been filed, in such registration 
statement), with such changes or insertions as are required by Rule 430A 
under the Act or permitted by Rule 424(b) under the Act and as have been 
provided to and approved by the Representatives prior to the execution of 
this Agreement, or (b) if such registration statement, as it may have been 
amended, has not been declared by the Commission to be effective under the 
Act, an amendment to such registration statement, including a form of 
prospectus, a copy of which amendment has been furnished to and approved by 
the Representatives prior to the execution of this Agreement.  As used in 
this Agreement, the term "Registration Statement" means such registration 
statement on Form SB-2 and all amendments thereto, including the prospectus, 
all exhibits and financial statements, as it becomes effective; the term 
"Preliminary Prospectus" means each prospectus included in said Registration 
Statement before it becomes effective; and the term "Prospectus" means the 
prospectus first filed with the Commission pursuant to Rule 424(b) under the 
Act or, if no prospectus is required to be filed pursuant to said Rule 424(b),
such term means the prospectus included in the Registration Statement when it
becomes effective.

          2.2  ACCURACY OF REGISTRATION STATEMENT AND PROSPECTUS. Neither the 
Commission nor the "blue sky" or securities authority of any jurisdiction has 
issued any order preventing or suspending the use of any Preliminary Prospectus.
When (a) any Preliminary Prospectus was filed with the Commission,  (b) the 
Registration Statement or any amendment thereto was or is declared effective, 
and (c) the Prospectus or any amendment or supplement thereto is filed with 
the Commission pursuant to Rule 424(b) (or, if the Prospectus or such amendment
or supplement is not required to be so filed, when the Registration Statement 
or the amendment thereto containing such amendment or supplement to the 
Prospectus was or is declared effective) and on the Closing Date the Prospectus,
as amended or supplemented at any such time, such filing (i) contained or 
will contain all statements required to be stated therein in accordance with, 
and complied or will comply in all material respects with the requirements 
of, the Act and the rules and regulations of the Commission promulgated 
thereunder (the "Rules and Regulations") and (ii) did not or will not include 
any untrue statement of a material fact or omit to state any material fact 
necessary to make the statements therein not misleading in light of the 
circumstances under which they were made. The foregoing representation does 
not apply to statements or omissions made in any Preliminary Prospectus, the 
Registration Statement or any amendment thereto or the Prospectus or any 
amendment or supplement thereto in reliance upon and in conformity with 
written information furnished to the Company by any Underwriter through the 
Representatives specifically for use therein.


                                       2



          2.3  INCORPORATION AND STANDING.  The Company has been duly 
incorporated and is validly existing as a corporation in good standing under 
the laws of the State of California and is duly qualified to transact 
business as a foreign corporation and is in good standing under the laws of 
all other jurisdictions where the ownership or leasing of its properties or 
the conduct of its business requires such qualification, except where the 
failure to be so qualified does not amount to a material liability or 
disability to the Company. 

          2.4  DUE POWER AND AUTHORITY.  The Company has full corporate power 
to own or lease its properties and conduct its business as described in the 
Registration Statement and the Prospectus or, if the Prospectus is not in 
existence, the most recent Preliminary Prospectus; and the Company has full 
corporate power to enter into this Agreement and to carry out all the terms 
and provisions hereof to be carried out by it.  The execution and delivery of 
this Agreement and consummation of the transactions contemplated herein have 
been duly authorized by the Company and this Agreement has been duly executed 
and delivered by the Company and constitutes the legal, valid and binding 
obligation of the Company, enforceable against the Company in accordance with 
the terms thereof, except as may be limited by applicable bankruptcy, 
insolvency, reorganization or similar laws affecting creditors' rights 
generally and by general equitable principles, and as rights to indemnity and 
contribution hereunder may be limited by applicable law.  

          2.5  CONSENTS; NO DEFAULTS.  The issuance, offering and sale of the 
Shares to the Underwriters by the Company pursuant to this Agreement, the 
compliance by the Company with the other provisions of this Agreement and the 
consummation of the other transactions herein contemplated do not (a) require 
the consent, approval, authorization, registration or qualification of or 
with any governmental authority, except such as have been obtained, or as may 
be required under the Act or under the securities or blue sky laws of any 
jurisdiction, or (b) conflict with or result in a breach or violation of any 
of the terms and provisions of, or constitute a default under, any indenture, 
mortgage, deed of trust, lease or other material agreement or instrument to 
which the Company is a party or by which the Company or any of its properties 
is bound, or the charter documents or bylaws of the Company, or any statute 
or any judgment, decree, order, rule or regulation of any court or other 
governmental authority or any arbitrator applicable to the Company.

          2.6  NO BREACH OR DEFAULT.  The Company is not in breach of any 
term or provision of its Articles of Incorporation or Bylaws; no default 
exists, and no event has occurred which with notice or lapse of time or both, 
would constitute a default, in the Company's due performance and observance 
of any term, covenant or condition of any indenture, mortgage, deed of trust, 
lease, note, bank loan or credit agreement or any other material agreement or 
instrument to which the Company or its properties may be bound or affected in 
any respect which would have a material adverse effect on the condition 
(financial or otherwise), business, properties, prospects, net worth or 
results of operations of the Company.

          2.7  LICENSES.  Except as described in the Prospectus, the Company 
possesses all certificates, authorizations and permits issued by the 
appropriate federal, state or foreign regulatory authorities necessary for 
the conduct of its business, including without limitation the Food and Drug 


                                       3



Administration, the United States Department of Agriculture and the 
Environmental Protection Agency, and the Company has not received any notice 
of proceedings relating to the revocation or modification of any such 
certificate, authorization or permit which, singly or in the aggregate, if 
the subject of an unfavorable decision, ruling or finding, would result in a 
material adverse change in the condition (financial or otherwise), business 
prospects, net worth or results of operations of the Company, except as 
described in or contemplated by the Registration Statement.  Each approval, 
registration, qualification, license, permit, consent, order, authorization, 
designation, declaration or filing by or with any regulatory, administrative 
or other governmental body or agency necessary in connection with the 
execution and delivery by the Company of this Agreement and the consummation 
of the transactions contemplated (except such additional actions as may be 
required by the National Association of Securities Dealers, Inc. or may be 
necessary to qualify the Common Stock for public offering under state 
securities or blue sky laws) has been obtained or made and each is in full 
force and effect.

          2.8  COMPLIANCE WITH LAWS.  Except as disclosed in the Registration 
Statement and in the Prospectus (or, if the Prospectus is not in existence, 
the most recent Preliminary Prospectus), the Company is not in violation of 
any laws, ordinances, governmental rules or regulations to which it is subject,
which would have a material adverse effect on the condition (financial or 
otherwise), business, properties, prospects, net worth or results of operations
of the Company.

          2.9  EXISTING CAPITAL STRUCTURE AND SHAREHOLDER RIGHTS. The Company 
has an authorized, issued and outstanding capitalization as set forth in, and 
capital stock conforms in all material respects to the description contained 
in, the Prospectus or, if the Prospectus is not in existence, the most recent 
Preliminary Prospectus.  Except as described in the Registration Statement 
and in the Prospectus there are no outstanding (a) securities or obligations 
of the Company convertible into or exchangeable for any capital stock of the 
Company, (b) warrants, rights or options to subscribe for or purchase from 
the Company any such capital stock or any such convertible or exchangeable 
securities or obligations, or (c) obligations of the Company to issue such 
shares, any such convertible or exchangeable securities or obligations, or 
any such warrants, rights or obligations. All of the issued shares of capital 
stock of the Company have been duly authorized and validly issued and are 
fully paid and nonassessable, and have been issued in compliance with all 
federal and state securities laws.  No preemptive rights of shareholders 
exist with respect to any capital stock of the Company.  No shareholder of 
the Company has any right pursuant to any agreement which has not been waived 
or honored to require the Company to register the sale of any securities 
owned by such shareholder under the Act in the public offering contemplated 
herein except as disclosed in the Registration Statement.  The Company has 
no subsidiaries, and does not own any shares of stock or any other equity 
interest in any firm, partnership, association or other entity.

          2.10 AUTHORITY FOR ISSUANCE OF SHARES.  The issuance of the Common 
Stock issuable in connection with the Shares has been duly authorized and at 
any Firm or Option Closing Date as defined herein after payment therefor in 
accordance herewith, such Common Stock will be validly issued, fully paid and 
nonassessable.  The Shares will conform in all material respects with all 
statements with regard thereto in the Registration Statement and the Prospectus.


                                       4



          2.11 TITLE TO TANGIBLE PROPERTY.  Except as otherwise set forth in 
or contemplated by the Registration Statement and Prospectus, the Company has 
good and marketable title to all items of personal property owned by the 
Company, free and clear of any security interest, liens, encumbrances, 
equities, claims and other defects, except such as do not materially and 
adversely affect the value of such property and do not materially interfere 
with the use made or proposed to be made of such property by the Company, and 
any real property and buildings held under lease by the Company are held 
under valid, subsisting and enforceable leases, with such exceptions as are 
not material and do not materially interfere with the use made or proposed to 
be made of such property and buildings by the Company.

          2.12 TITLE TO INTELLECTUAL PROPERTY.  The Company owns the 
trademarks and intellectual property described in the Registration Statement. 
 The Company does not own any patents.  The Company owns or possesses, or can 
acquire on reasonable terms, all material, trademarks, service marks, trade 
names, licenses, copyrights and proprietary or other confidential information 
currently employed by it in connection with its business, and the Company has 
not received any notice of infringement of or conflict with asserted rights 
of any third party with respect to any of the foregoing intellectual property 
rights which, singly or in the aggregate, if the subject of an unfavorable 
decision, ruling or finding would result in a material adverse change in the 
condition (financial or otherwise), business prospects, net worth or results 
of operations of the Company, except as described in or contemplated by the 
Prospectus.

          2.13 CONTRACT RIGHTS.  The agreements to which the Company is a 
party described in the Registration Statement and Prospectus are valid 
agreements, enforceable by the Company in accordance with their terms, except 
as the enforcement thereof may be limited by applicable bankruptcy, 
insolvency, reorganization, moratorium or other similar laws relating to or 
affecting creditor's rights generally or by equitable principles, and, to the 
Company's knowledge, the other contracting party or parties thereto are not 
in material breach or material default under any of such agreements.

          2.14 NO MARKET MANIPULATION.  The Company has not taken nor will it 
take, directly or indirectly, any action designed to cause or result, or 
which might reasonably be expected to cause or result, in the stabilization 
or manipulation of the price of any security of the Company to facilitate the 
sale or resale of the Common Stock.

          2.15 NO OTHER SALES OR COMMISSIONS.  The Company has not since the 
filing of the Registration Statement (i) sold, bid for, purchased, attempted 
to induce any person to purchase, or paid anyone any compensation for 
soliciting purchases of, its capital stock or (ii) paid or agreed to pay to 
any person any compensation for soliciting another to purchase any securities 
of the Company except for the sale of Shares by the Company under this 
Agreement.


                                       5



          2.16 ACCURACY OF FINANCIAL STATEMENTS. The financial statements and 
schedules of the Company included in the Registration Statement and the 
Prospectus, or, if the Prospectus is not in existence, the most recent 
Preliminary Prospectus, fairly present in all material respects the financial 
position of the Company and the results of operations and changes in 
financial condition as of the dates and periods therein specified.  Such 
financial statements and schedules have been prepared in accordance with 
generally accepted accounting principles consistently applied throughout the 
periods involved except as otherwise noted therein and include all financial 
information required to be included by the Act.  The selected financial data 
set forth under the captions "PROSPECTUS SUMMARY--Summary Financial 
Information," "SELECTED FINANCIAL DATA" and "MANAGEMENT'S DISCUSSION AND 
ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS" in the Prospectus, 
or, if the Prospectus is not in existence the most recent Preliminary 
Prospectus, fairly present in all material respects, on the basis stated in 
the Prospectus or such Preliminary Prospectus, the information included 
therein.

          2.17 INDEPENDENT PUBLIC ACCOUNTANT.  Semple & Cooper, which have 
certified or shall certify certain of the financial statements of the Company 
filed or to be filed as part of the Registration Statement and the Prospectus,
are independent certified public accountants within the meaning of the Act 
and the Rules and Regulations.

          2.18 INTERNAL ACCOUNTING.  The Company maintains a system of 
internal accounting controls sufficient to provide reasonable assurance that 
(a) transactions are executed in accordance with management's general or 
specific authorization; (b) transactions are recorded as necessary to permit 
preparation of financial statements in conformity with generally accepted 
accounting principles and to maintain asset accountability; (c) access to 
assets is permitted only in accordance with management's general or specific 
authorization; and (d) the recorded accountability for assets is compared 
with the existing assets at reasonable intervals and appropriate action is 
taken with respect to any differences.

          2.19 LITIGATION.  Except as set forth in the Registration Statement 
and Prospectus, there is and at the Closing Date there will be no action, 
suit or proceeding before any court or governmental agency, authority or body 
pending or to the knowledge of the Company threatened which might result in 
judgments against the Company not adequately covered by insurance or which 
collectively might result in any material adverse change in the condition 
(financial or otherwise), the business or the prospects of the Company, or 
would have a material adverse effect on the properties or assets of the 
Company.  The Company is not subject to the provisions of any injunction, 
judgement, decree or order of any court, regulatory body, administrative 
agency or other governmental body or arbitral forum, which might result in a 
material adverse change in the business, assets or condition of the Company.

          2.20 NO MATERIAL ADVERSE CHANGE.  Subsequent to the respective 
dates as of which information is given in the Registration Statement and the 
Prospectus (or, if the Prospectus is not in existence, the most recent 
Preliminary Prospectus), (a) the Company has not incurred any material 
adverse change in or affecting the condition, financial or otherwise, of the 
Company or the earnings, 


                                      6



business affairs, management, or business prospects of the Company, whether 
or not occurring in the ordinary course of business, (b) there has not been 
any material transaction entered into by the Company, other than transactions 
in the ordinary course of business or transactions specifically described in 
the Registration Statement as it may be amended or supplemented, (c) the 
Company has not sustained any material loss or interference with its business 
or properties from fire, flood, windstorm, accident or other calamity, (d) 
the Company has not paid or declared any dividends or other distribution with 
respect to its capital stock and the Company is not in default in the payment 
of principal or interest on any outstanding debt obligations, and (e) there 
has not been any change in the capital stock (other than the sale of the 
Common Stock hereunder or the exercise of outstanding stock options or 
warrants as described in the Registration Statement) or material increase in 
indebtedness of the Company.  The Company does not have any known material 
contingent obligation which is not disclosed in the Registration Statement 
(or contained in the financial statements or related notes thereto), as such 
may be amended or supplemented.

          2.21 TRANSACTIONS WITH AFFILIATES.  Subsequent to the respective 
dates as of which information is given in the Registration Statement and 
Prospectus or if the Prospectus is not in existence the most recent 
Preliminary Prospectus, and except as may otherwise be indicated or 
contemplated herein or therein, (a) the Company has not entered into any 
transaction with an "affiliate" of the Company, as defined in the Act and the 
Rules and Regulations, or (b) declared, paid or made any dividend or 
distribution of any kind on or in connection with any class of its capital 
stock, and (c) the Company has no knowledge of any transaction between any 
affiliate of the Company and any significant customer or supplier of the 
Company, except in its ordinary course of business.

          2.22 INSURANCE.  Except as otherwise set forth in or contemplated 
by the Registration Statement and Prospectus, the Company is insured by 
insurers of recognized financial responsibility against such losses and risks 
and in such amounts as are prudent and customary in the business in which it 
is engaged, including without limitation products liability insurance; the 
Company has not been refused any insurance coverage sought or applied for; 
and the Company has no reason to believe that it will not be able to renew 
its existing insurance coverage as and when such coverage expires or to 
obtain similar coverage from similar insurers as may be necessary to continue 
its business at a cost that would not materially and adversely affect the 
condition (financial or otherwise), business prospects, net worth or results 
of operations of the Company.

          2.23 TAX RETURNS.  The Company has filed all foreign, federal, 
state and local tax returns that are required to be filed or has requested 
extensions thereof and has paid all taxes required to be paid by it and any 
other assessment, fine or penalty levied against it, to the extent that any 
of the foregoing is due and payable or adequate accruals have been set up to 
cover any such unpaid taxes, except for any such assessment, fine or penalty 
that is currently being contested in good faith.


                                      7



          2.24 POLITICAL CONTRIBUTIONS.  The Company has not directly or 
indirectly, (a) made any unlawful contribution to any candidate for public 
office, or failed to disclose fully any contribution in violation of law, or 
(b) made any payment to any federal, state, local, or foreign governmental 
officer or official, or other person charged with similar public or 
quasi-public duties, other than payments required or permitted by the laws of 
the United States or any other such jurisdiction.

          2.25 RELATIONSHIPS WITH CUSTOMERS, SUPPLIERS AND MANUFACTURERS.  
The Company does not currently have any written contracts with any of its 
customers, suppliers and manufacturers.  The Company is in compliance with 
all oral agreements with its customers, suppliers and manufacturers.  The 
Company has not received notice from any of its customers, suppliers and 
manufacturers alleging any breach of contract, representation or warranty 
which, in the aggregate, would have a material adverse effect on the 
financial condition or operations results of the Company.

          2.26 INVESTMENT COMPANY ACT.  The Company conducts its operations 
in a manner that does not subject it to registration as an investment company 
under the Investment Company Act of 1940, as amended, and the transactions 
contemplated by this Agreement will not cause the Company to become an 
investment company subject to registration under the Investment Company Act 
of 1940, as amended.


                                  SECTION 3.
                 PURCHASE, SALE AND DELIVERY OF THE SHARES

          3.1  PURCHASE OF FIRM SHARES.  On the basis of the representations, 
warranties, agreements and covenants herein contained and subject to the 
terms and conditions herein set forth, the Company agrees to issue and sell 
to each of the Underwriters named in Schedule I hereto, and each of the 
Underwriters, severally and not jointly, agrees to purchase from the Company, 
at a purchase price of $4.50 per Share, the number of Firm Shares set forth 
opposite the name of such Underwriter in Schedule 1 hereto. The Company will 
make one or more certificates for Common Stock constituting the Firm Shares, 
in definitive form and in such denomination or denominations and registered 
in such name or names as the Representatives shall request upon notice to the 
Company at least 48 hours prior to the Firm Closing Date, available for 
checking and packaging by the Representatives at the offices of the Company's 
transfer agent or registrar (or the correspondent or the agent of the 
Company's transfer agent or registrar) at least 24 hours prior to the Firm 
Closing Date.  Payment for the Firm Shares shall be made by bank wire payable 
in same day funds to the order of the Company drawn to the order of the 
Company for the Firm Shares, against delivery of certificates therefor to the 
Representatives.  Delivery of the documents, certificates and opinions 
described in Section 6 of this Agreement, the Firm Shares and payment for the 
Firm Shares and the Option Shares shall be made at the offices of Sentra 
Securities Corporation, 2355 Northside Drive, Suite 200, San Diego, 
California 92108, at 9:00 a.m., San Diego time, on the third full business 
day following the date hereof (on the fourth full business day if this 
Agreement is executed after 1:30 p.m., San Diego time), or at such other 
places, time or date as the Representatives and the Company 


                                      8



may agree upon or as the Representatives may determine pursuant to Section 9 
hereof, such time and date of delivery against payment being herein referred 
to as the "Firm Closing Date" or "Closing Date" as applicable. 

          3.2  OVER-ALLOTMENTS; OPTION SHARES.  For the purpose of covering 
any over-allotments in connection with the distribution and sale of the Firm 
Shares as contemplated by the Prospectus, the Company hereby grants to you on 
behalf of the several Underwriters an option to purchase, severally and not 
jointly, the Option Shares.  The purchase price to be paid for any Option 
Shares shall be the same price per share as the price per Share for the Firm 
Shares set forth above in Section 3.1, plus, if the purchase and sale of any 
Option Share takes place after the Firm Closing Date and after the Common 
Stock is trading "ex-dividend," an amount equal to the dividends payable on 
the Common Stock contained in such Option Shares.  The option granted hereby 
may be exercised in the manner described below as to all or any part of the 
Option Shares from time to time within forty-five days after the date of the 
Prospectus.  The Underwriters shall not be under any obligation to purchase 
any of the Option Shares prior to the exercise of such option.  The 
Representatives may from time to time exercise the option granted hereby by 
giving notice in writing or by telephone (confirmed in writing) to the 
Company setting forth the aggregate number of Option Shares as to which the 
several Underwriters are then exercising the option and the date and time for 
delivery of and payment for such Option Shares.  Any such date of delivery 
shall be determined by the Representatives but shall not be earlier than two 
business days or later than seven business days after such exercise of the 
option and, in any event, shall not be earlier than the Firm Closing Date.  
The time and date set forth in such notice, or such other time on such other 
date as the Representatives and the Company may agree upon or as the 
Representatives may determine pursuant to Section 9 hereof, is herein called 
the "Option Closing Date" with respect to such Option Shares.  Upon each 
exercise of the option as provided herein, subject to the terms and 
conditions herein set forth, the Company shall become obligated to sell to 
each of the several Underwriters, and each of the Underwriters (severally and 
not jointly) shall become obligated to purchase from the Company, the same 
percentage of the total number of the Option Shares as to which the several 
Underwriters are then exercising the option as such Underwriter is obligated 
to purchase of the aggregate number of Firm Shares, as adjusted by the 
Representatives in such manner as it deems advisable to avoid fractional 
shares.  If the option is exercised as to all or any portion of the Option 
Shares, one or more certificates for the Common Stock contained in such 
Option Shares,  in definitive form, and payment therefore, shall be delivered 
on the related Option Closing Date in the manner, and upon the terms and 
conditions, set forth in Section 3.1, except that reference therein to the 
Firm Shares and the Firm Closing Date shall be deemed, for purposes of this 
Section 3.2, to refer to such Option Shares and Option Closing Date, 
respectively.  No Option Shares shall be required to be, or be, sold and 
delivered unless the Firm Shares have been, or simultaneously are, sold and 
delivered as provided in this Agreement.

          3.3  DEFAULT BY AN UNDERWRITER.  It is understood that you, 
individually and not as the Representatives, may (but shall not be obligated 
to) make payment on behalf of any Underwriter or Underwriters for any of the 
Shares to be purchased by such Underwriter or Underwriters.  No such 


                                      9



payment shall relieve such Underwriter or Underwriters from any of its or 
their obligations hereunder.

                                  SECTION 4.
                        OFFERING BY THE UNDERWRITERS

     Upon payment by the Underwriters of the purchase price of $4.50 per 
Share and the Company's authorization of the release of the Firm Shares, the 
several Underwriters shall offer the Firm Shares for sale to the public upon 
the terms set forth in the Prospectus.  The Representatives may from time to 
time thereafter change the public offering prices and other selling terms.  
If the option set forth in Section 3.2 of this Agreement is exercised, then 
upon the Company's authorization of the release of the Option Shares the 
several Underwriters shall offer such Shares for sale to the public upon the 
foregoing terms.

                                  SECTION 5.
                          COVENANTS OF THE COMPANY

     Except as otherwise stated below, the Company covenants and agrees with 
each of the Underwriters that:

          5.1  COMPANY'S BEST EFFORTS TO CAUSE REGISTRATION STATEMENT TO 
BECOME EFFECTIVE.  The Company will use its best efforts to cause the 
Registration Statement, if not effective at the time of execution of this 
Agreement, and any amendments thereto, to become effective as promptly as 
possible.  If required, the Company will file the Prospectus and any 
amendment or supplement thereto with the Commission in the manner and within 
the time period required by Rule 424(b) under the Act.  During any time when 
a prospectus relating to the Common Stock is required to be delivered under 
the Act, the Company (a) will comply with all requirements imposed upon it by 
the Act and the Rules and Regulations to the extent necessary to permit the 
continuance of sales of or dealings in the Common Stock in accordance with 
the provisions hereof and of the Prospectus, as then amended or supplemented, 
and (b) will not file with the Commission the prospectus or the amendment 
referred to in the second sentence of Section 2.1 hereof, any amendment or 
supplement to such prospectus or any amendment to the Registration Statement 
unless and until the Representatives have been advised of such proposed 
filing, has been furnished with a copy for a reasonable period of time prior 
to the proposed filing, and has given its consent to such filing, which shall 
not be unreasonably withheld or delayed.

          5.2  PREPARATION AND FILING OF AMENDMENTS AND SUPPLEMENTS.  The 
Company will prepare and file with the Commission, in accordance with the 
Rules and Regulations of the Commission, promptly upon written request by the 
Representatives or counsel for the Representatives, any amendments to the 
Registration Statement or amendments or supplements to the Prospectus that 
may be reasonably necessary or advisable in connection with the distribution 
of the Shares by the several Underwriters, and the Company will use its best 
efforts to cause any such 


                                     10



amendment to the Registration Statement to be declared effective by the 
Commission as promptly as possible.  The Company will advise the 
Representatives, promptly after receiving notice thereof, of the time when 
the Registration Statement or any amendment thereto has been filed or 
declared effective or the Prospectus or any amendment or supplement thereto 
has been filed and will provide evidence satisfactory to the Representatives 
of each such filing or effectiveness.

          5.3  NOTICE OF STOP ORDERS.  The Company will advise the 
Representatives promptly after receiving notice or obtaining knowledge of: 
(a) the issuance by the Commission of any stop order suspending the 
effectiveness of the Registration Statement or any amendment thereto, or any 
order preventing or suspending the use of any Preliminary Prospectus of the 
Prospectus or any amendment or supplement thereto; (b) the suspension of the 
qualification of the Shares for offering or sale in any jurisdiction; (c) the 
institution, threatening or contemplation of any proceeding for any such 
purpose; or (d) any request made by the Commission for amending the 
Registration Statement, for amending or supplementing the Prospectus or for 
additional information.  The Company will use its best efforts to prevent the 
issuance of any such stop order and, if any such stop order is issued to 
obtain the withdrawal thereof as promptly as possible.

          5.4  BLUE SKY QUALIFICATION.  The Company will arrange and 
cooperate with counsel to the Representatives for the qualification of the 
Shares for offering and sale under the securities or blue sky laws of such 
jurisdictions as the Representatives may designate and will continue such 
qualifications in effect for as long as may be necessary to complete the 
distribution of the Shares; provided, however, that in connection therewith 
the Company shall not be required to qualify as a foreign corporation or to 
execute a general consent to service of process in any jurisdiction.

          5.5  POST-EFFECTIVE AMENDMENTS.  If, at any time when a prospectus 
relating to the Shares is required to be delivered under the Act, any event 
occurs as a result of which the Prospectus, as then amended or supplemented, 
would include any untrue statement of a material fact or omit to state a 
material fact necessary in order to make the statements therein not 
misleading, in the light of the circumstances under which they were made, or 
if for any other reason it is necessary at any time to amend or supplement 
the Prospectus to comply with the Act or the Rules or Regulations, the 
Company will promptly notify the Representatives thereof and, subject to 
Section 3 hereof, will prepare and file with the Commission, at the Company's 
expense, an amendment to the Registration Statement or an amendment or 
supplement to the Prospectus that corrects such statement or omission or 
effects such compliance.

          5.6  DELIVERY OF PROSPECTUSES.  The Company will, without charge, 
provide (a) to the Representatives and to counsel for the Representatives a 
signed copy of the Registration Statement originally filed with respect to 
the Shares and each amendment thereto (in each case including exhibits 
thereto), (b) to each other Underwriter so requesting in writing, a conformed 
copy of such Registration Statement and each amendment thereto (in each case 
without exhibits thereto) and (c) so long as a prospectus relating to the 
Shares is required to be delivered under the Act, as 



                                      11

                                       
many copies of each Preliminary Prospectus or the Prospectus or any amendment 
or supplement thereto as the Representatives may reasonably request. 

          5.7  SECTION 11(a) FINANCIALS.  The Company will, as soon as 
practicable but in any event not later than 90 days after the period covered 
thereby, make generally available to its security holders and to the 
Representatives a consolidated earnings statement of the Company and its 
subsidiaries that satisfies the provisions of Section 11(a) of the Act and 
Rule 158 thereunder covering a twelve-month period beginning not later than 
the first day of the Company's fiscal quarter next following the effective 
date of the Registration Statement.

          5.8  APPLICATION OF PROCEEDS.  The Company will apply the net 
proceeds from the sale of the Shares as set forth in the Prospectus and 
Registration Statement and will not take any action that would cause it to 
become an investment company under the Investment Company Act of 1940, as 
amended.

          5.9  SALES OR PURCHASES OF SECURITIES.  The Company will not, 
directly or indirectly, without the prior written consent of the 
Representatives, offer, sell, grant any option or warrant to purchase or 
otherwise dispose (or announce any offer, sale, grant of any option to 
purchase or other disposition) of any shares of Common Stock or any 
securities convertible into, or exchangeable or exercisable for, shares of 
Common Stock for a period of one year after the date hereof, except (a) to 
the Underwriters pursuant to this Agreement and (b) options to any person 
pursuant to and in accordance with the Company's 1995 Incentive Stock Option 
Plan, as such plan is in effect on the date hereof, and provided that (i) 
such options have an exercise price equal to the fair market value of the 
Common Stock, and (ii) such person has delivered to the Representatives the 
agreement described in Section 7.8 of this Agreement.  The Company will not, 
directly or indirectly, without the prior written consent of the 
Representatives purchase any Common Stock or any securities convertible into, 
or exercisable for, shares of Common Stock for a period of one year after the 
date hereof.

          5.10 APPLICATION TO NASDAQ SMALLCAP MARKET.  The Company will cause 
the Common Stock and Warrants to be duly included for quotation on the Nasdaq 
SmallCap Market prior to the Closing Date.  If requested by the 
Representatives, the Company will also cause the Common Stock to be duly 
included for listing on the Pacific Stock Exchange.  The Company will use its 
best efforts to ensure that the Common Stock remains included for quotation 
on the Nasdaq SmallCap Market and the Pacific Stock Exchange (if applicable) 
following the Closing Date for a period of not less than three years.

          5.11 REPORTS TO SHAREHOLDERS.  So long as any Common Stock is 
outstanding until five years after the Closing Date, the Company will furnish 
to the Representatives (a) as soon as available a copy of each report of the 
Company mailed to shareholders and filed with the Commission and (b) from 
time to time such other information concerning the Company as the 
Representatives may reasonably request.



                                      12

                                       
          5.12 DELIVERY OF DOCUMENTS.  At or prior to the Closing, the 
Company will deliver to the Representatives true and correct copies of the 
articles of incorporation of the Company and all amendments thereto, all such 
copies to be certified by the Secretary of State of the State of California, 
a good standing certificate from the Secretary of State of California, dated 
no more than five business days prior to the Closing Date; true and correct 
copies of the bylaws of the Company, as amended, certified by the Secretary 
of the Company and true and correct copies of the minutes of all meetings of 
the directors and shareholders of the Company held prior to the Closing Date 
which in any way relate to the subject matter of this Agreement.

          5.13 UNDERWRITERS' WARRANT.   On or prior to the Closing Date, the 
Company shall deliver to the Representatives warrants (the "Underwriter's 
Warrants"), at an aggregate purchase price of $100, to purchase Shares equal 
to 10% of the Firm Shares sold in the Offering, which Underwriter's Warrants 
shall be exercisable for a per Share exercise price equal to 120% of the per 
Share public offering price of the Firm Shares. 

          5.14 COOPERATION WITH REPRESENTATIVES' DUE DILIGENCE.  At all times 
prior to the Closing Date, the Company will cooperate with the 
Representatives in such investigation as the Representatives may make or 
cause to be made of all the properties, business and operations of the 
Company in connection with the purchase and public offering of the Shares and 
the Company will make available to the Representatives in connection 
therewith such information in its possession as the Representatives may 
reasonably request.

          5.15 STOCK TRANSFER AGENT.  The Company has appointed Corporate 
Stock Transfer, Inc. , Denver, Colorado, as Transfer Agent for the Common 
Stock.  The Company will  not change or terminate such appointment for a 
period of two years from the effective date without first obtaining the 
written consent of the Representatives, which consent shall not be 
unreasonably withheld.

          5.16 PUBLICITY.  Prior to the Firm Closing Date, or the Option 
Closing Date, as the case may be, the Company shall not issue any press 
release or other communication directly or indirectly and shall hold no press 
conference with respect to the Company, its financial condition, results of 
operations, business, properties, assets, liabilities and any of them, or 
this offering, without the prior written consent of the Representatives.  If 
at any time during the 90 day period after the Registration Statement becomes 
effective, any rumor, publication or event relating to or affecting the 
Company shall occur as a result of which in the opinion of the 
Representatives the market price of the Common Stock has been or is likely to 
be materially affected, regardless of whether such rumor, publication or 
event necessitates a supplement to or amendment of the Prospectus, the 
Company will, after written notice from the Representatives, evaluate the 
propriety of  disseminating a press release or other public statement 
reasonably acceptable to the Representatives and their counsel, commenting on 
such rumor, publication or event.



                                      13

                                       
          5.17 FORECASTS AND PROJECTIONS.   For a period of two years from 
the effective date of the Registration Statement, the Company shall provide 
the Representatives with routine internal forecasts if any such reports are 
prepared by the Company for dissemination to the public.

          5.18 KEY MAN INSURANCE; DIRECTOR AND OFFICER LIABILITY INSURANCE.  
The Company will maintain for a period of at least five (5) years, Key Man 
Insurance on Floyd Hill in the amount of $1,000,000.  The Company will also 
maintain for a period of at least five (5) years, Director and Officer 
Liability insurance in the amount of at least $5,000,000. The Representatives 
reserve the right to write the above policies at the next renewal date 
thereof providing it can do so on terms no less favorable to the Company.

          5.19 COMPANY'S BOARD OF DIRECTORS.  The Company will maintain a 
professional board of directors that will at all times include at least two 
outside directors.  The Company shall appoint two individuals recommended by 
Representatives to the Company's Board of Directors which recommendation 
shall be made by Representatives after the Closing Date.

                                       
                                   SECTION 6.
                                    Expenses

          6.1  OFFERING EXPENSES.  The Company will pay upon demand all costs 
and expenses incident to the performance of the Company's obligations under 
this Agreement, whether or not the transactions contemplated herein are 
consummated or this Agreement is terminated pursuant to Section 11 hereof, 
including all costs and expenses incident to (a) the printing or other 
production of documents with respect to the transactions, including any costs 
of printing the Registration Statement originally filed with respect to the 
Shares and any amendment thereto, any Preliminary Prospectus and the 
Prospectus and any amendment or supplement thereto, this Agreement, the 
Agreement Among Underwriters, the Selected Dealer Agreement, and any blue sky 
memoranda, (b) all arrangements relating to the delivery to the Underwriters 
of copies of the foregoing documents, (c) the fees and disbursements of 
counsel, accountants and any other experts or advisors retained by the 
Company, (d) preparation, issuance and delivery to the Underwriters of any 
certificates evidencing the Common Stock, including transfer agent's and 
registrar's fees, (e) the qualification of the Shares under state securities 
and blue sky laws, including filing fees and fees and disbursements of 
counsel for the Representatives relating thereto, (f) the filing fees of the 
Commission and the National Association of Securities Dealers, Inc. relating 
to the Shares, (g) any listing fees for the quotation of the Common Stock on 
the Nasdaq SmallCap Market, (h) the entire cost of one "tombstone 
advertisement" in a national business newspaper and one-half the cost of 
placing any additional "tombstone advertisements" in any publications which 
may be selected by the Representatives (provided that any such cost in excess 
of $5,000 shall require the consent of both the Company and the 
Representatives), (i) all other advertising that has been approved in advance 
by the Company relating to the offering of the Shares (other than as shall 
have been specifically approved in writing by the Representatives to be paid 
for by the Underwriters), and (j) road shows conducted by the Company.  In 
addition to the foregoing, the Company agrees to pay to the Representatives a 
non-accountable expense allowance of 3% of the gross amount to be raised from 



                                      14

                                       
the sale of the Shares hereunder, payable at the Closing(s), of which $50,000 
has already been paid by the Company in connection with this offering.  If 
the sale of the Shares provided for herein is not consummated because any 
condition to the obligations of the Underwriters set forth in Section 7 
(other than Section 7.6) hereof is not satisfied, because this Agreement is 
terminated pursuant to Section 11 hereof or because of any failure, refusal 
or inability on the part of the Company to perform all obligations and 
satisfy all conditions on its part to be performed or satisfied hereunder 
other than by reason of a default by any of the Underwriters, the Company 
will reimburse the Underwriters severally upon demand for all out-of-pocket 
expenses (including counsel fees and disbursements) that shall have been 
reasonably incurred by them in connection with the proposed purchase and sale 
of the Shares.  The Company shall in no event be liable to any of the 
Underwriters for the loss of anticipated profits from the transactions 
covered by this Agreement.

          6.2  INTERIM INDEMNIFICATION.  The Company agrees that as an 
interim measure during the pendency of any claim, action, investigation, 
inquiry or other proceeding described in Section 8.1 hereof, it will 
reimburse the Underwriters on a monthly basis for all reasonable legal or 
other expenses incurred in connection with investigating or defending any 
such claim, action, investigation, inquiry or other proceeding, 
notwithstanding the absence of a judicial determination as to the propriety 
and enforceability of the Company's obligation to reimburse the Underwriters 
for such expenses and the possibility that such payments might later be held 
to have been improper by a court of competent jurisdiction.  To the extent 
that any such interim reimbursement payment is so held to have been improper, 
the Underwriters shall promptly return such payment to the Company together 
with interest, compounded daily, determined on the basis of the prime rate 
(or other commercial lending rate for borrowers of the highest credit 
standing) listed from time to time in THE WALL STREET JOURNAL which 
represents the base rate on corporate loans posted by a substantial majority 
of the nation's thirty (30) largest banks (the "Prime Rate").  Any such 
interim reimbursement payments which are not made to the Underwriters within 
thirty (30) days of a request for reimbursement shall bear interest at the 
Prime Rate from the date of such request.

     The Underwriters severally and not jointly agree that, as an interim 
measure during the pendency of any claim, action, investigation, inquiry or 
other proceeding described in Section 8.2 hereof, they will reimburse the 
Company on a monthly basis for all reasonable legal or other expenses 
incurred in connection with investigating or defending any such claim, 
action, investigation, inquiry or other proceeding, notwithstanding the 
absence of a judicial determination as to the propriety and enforceability of 
the Underwriters' obligation to reimburse the Company for such expenses and 
the possibility that such payments might later be held to have been improper 
by a court of competent jurisdiction.  To the extent that any such interim 
reimbursement payment is so held to have been improper, the Company shall 
promptly return such payment to the Underwriters together with interest, 
compounded daily, determined on the basis of the Prime Rate.  Any such 
interim reimbursement payments which are not made to the Company within 
thirty (30) days of a request for reimbursement shall bear interest at the 
Prime Rate from the date of such request.



                                      15

                                       
                                   SECTION 7.
                  CONDITIONS OF THE UNDERWRITERS' OBLIGATIONS

     The obligations of the several Underwriters to purchase and pay for the 
Firm Shares shall be subject, unless waived by the Representatives in its 
sole discretion, to the accuracy of the representations and warranties of the 
Company contained herein as of the date hereof and as of the Firm Closing 
Date as if made on and as of the Firm Closing Date, to the accuracy of the 
statements of the Company's officers made pursuant to the provisions hereof, 
to the performance by the Company of its covenants and agreements hereunder 
and to the following additional conditions:

          7.1  EFFECTIVENESS OF REGISTRATION STATEMENT.  If the Registration 
Statement or any amendment thereto filed prior to the Firm Closing Date has 
not been declared effective as of the time of execution hereof, the 
Registration Statement or such amendment shall have been declared effective 
not later than 11 a.m., California time, on the date on which the amendment 
to the Registration Statement originally filed with respect to the Shares or 
to the Registration Statement, as the case may be, containing information 
regarding the initial public offering price of the Shares has been filed with 
the Commission, or such later time and date as shall have been consented to 
by the Representatives; if required, the Prospectus and any amendment or 
supplement thereto shall have been filed with the Commission in the manner 
and within the time period required by Rule 424(b) under the Act; no stop 
order suspending the effectiveness of the Registration Statement or any 
amendment thereto shall have been issued, and no proceedings for that purpose 
shall have been instituted or threatened or, to the knowledge of the Company 
or the Representatives, shall be contemplated by the Commission; and the 
Company shall have complied with any request of the Commission for additional 
information (to be included in the Registration Statement or the Prospectus 
or otherwise) to the reasonable satisfaction of counsel for the underwriters.

          7.2  OPINION OF COUNSEL.  The Representatives shall have received 
an opinion, dated the Firm Closing Date, of Gary A. Agron, Esq., counsel for 
the Company, to the effect that:

               (a)    the Company has been duly organized and is validly 
existing as a corporation in good standing under the laws of the State of 
California, and duly qualified to transact business as a foreign corporation 
and is in good standing under the laws of all other jurisdictions where the 
ownership or leasing of its properties or the conduct of its business 
requires such qualification, except where the failure to be so qualified 
would not have a material adverse effect on the Company;

               (b)    the Company has the corporate power to own or lease its 
properties; to conduct its business as described in the Registration 
Statement and the Prospectus; to enter into this Agreement and to carry out 
all of the terms and provisions hereof to be carried out by it;

               (c)    the Company has an authorized capital stock as set 
forth under the heading "CAPITALIZATION" in the Prospectus; effective upon 
the Closing Date all of the Company's shares have been duly authorized and 
validly issued and are fully paid and nonassessable; 



                                      16

                                       
the shares have been duly authorized by all necessary corporate action of the 
Company, and, when issued and delivered to and paid for pursuant to this 
Agreement, will be validly issued, fully paid and nonassessable; the shares 
have been duly authorized for quotation on the Nasdaq SmallCap Market; no 
holders of outstanding shares of capital stock of the Company are entitled as 
such to any preemptive or other rights to subscribe for any of the Shares; 
and no holders of securities of the Company are entitled to have such 
securities registered under the Registration Statement;

               (d)    the capital stock of the Company conforms, as to legal 
matters, to the statements set forth under the heading "DESCRIPTION OF 
SECURITIES" in the Prospectus in all material respects;

               (e)    the execution and delivery of this Agreement have been 
duly authorized by all necessary corporate action of the Company and this 
Agreement is a valid and binding obligation of the Company except as rights 
to indemnity and contribution thereunder may be limited by applicable federal 
or state securities laws and except as such enforceability may be limited by 
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting 
the enforceability of creditors' rights generally and subject to general 
principles of equity; 

               (f)    no legal or governmental proceedings are pending to 
which the Company is a party or to which the property of the Company is 
subject that are required to be described in the Registration Statement or 
the Prospectus and are not described therein, and, to the best knowledge of 
such counsel, no such proceedings have been threatened against the Company or 
with respect to any of its properties that can reasonably be expected to, or, 
if determined adversely to the Company, would, in any individual case or in 
the aggregate, result in any material adverse change in the business, 
financial condition or results of operations of the Company;

               (g)    no contract or other document is required to be 
described in the Registration Statement or the Prospectus or to be filed as 
an exhibit to the Registration Statement that is not described therein or 
filed as required;

               (h)    the issuance, offering and sale of the Shares by the 
Company pursuant to this Agreement, the compliance by the Company with the 
other provisions of this Agreement and the consummation of the other 
transactions herein contemplated do not require the consent, approval, 
authorization, registration or qualification of or with any governmental 
authority, except such as have been obtained and such as may be required 
under state securities or blue sky laws, or conflict with or result in a 
breach or violation of any of the terms and provisions of, or constitute a 
default under, any indenture, mortgage, deed of trust, lease or other 
agreement or instrument, known to such counsel, to which the Company is a 
party or by which the Company or any of its properties are bound, or the 
Articles of Incorporation or Bylaws of the Company, or any statute or any 
judgment, decree, order, rule or regulation of any court or other 
governmental authority or any arbitrator known to such counsel and applicable 
to the Company; 



                                      17

                                       
               (i)    the Registration Statement is effective under the Act; 
any required filing of the Prospectus pursuant to Rule 424(b) has been made 
in the manner and within the time period required by Rule 424(b); and no stop 
order suspending the effectiveness of the Registration Statement or any 
amendment thereto has been issued by the Commission, and no proceedings for 
that purpose have been instituted or, to the knowledge of such counsel, are 
threatened or contemplated by the Commission;

               (j)    the Registration Statement and the Prospectus and each 
amendment or supplement thereto (in each case, other than the financial 
statements and other financial and statistical information contained therein, 
as to which such counsel need express no opinion) comply as to form in all 
material respects with the applicable requirements of the Act and the Rules 
and Regulations; 

               (k)    the Company is not required, and, if the Company uses 
the proceeds of the sale of the Firm Shares and the Option Shares solely as 
described in the Prospectus, will not be required as a result of the sale of 
such Shares to be registered as an investment company within the meaning of 
the Investment Company Act of 1940, as amended; and

               (l)    such counsel shall also state that they have no reason 
to believe that the Registration Statement, as of its effective date, 
contained any untrue statement of a material fact or omitted to state any 
material fact required to be stated therein or necessary to make the 
statements therein not misleading or that the Prospectus, as of its date or 
the date of such opinion, included or includes any untrue statement of a 
material fact or omitted or omits to state a material fact necessary in order 
to make the statements therein, in light of the circumstances under which 
they were made, not misleading; provided that in each case such counsel need 
not express any opinion as to the financial statements and other financial 
and statistical information contained therein.

In rendering any such opinion, such counsel may rely as to matters of fact, 
to the extent such counsel deems proper, on certificates of responsible 
officers of the Company and public officials.  The foregoing opinion may be 
limited to the laws of the United States and the General Corporation Law of 
the State of California. References to the Registration Statement and the 
Prospectus in this Section 7.2 shall include any amendment or supplement 
thereto at the date of such opinion.  Such counsel shall permit Luce, 
Forward, Hamilton & Scripps LLP to rely upon such opinion in rendering its 
opinion in Section 7.3.

          7.3  REVIEW BY AND OPINION OF REPRESENTATIVES' COUNSEL.  The 
Representatives shall have received an opinion, dated as of the Firm Closing 
Date, of Luce, Forward, Hamilton & Scripps LLP, counsel for the 
Representatives, with respect to certain matters as the Representatives may 
reasonably require, and the Company shall have furnished to such counsel such 
documents and certificates as they may reasonably request for the purpose of 
enabling them to opine upon such matters.



                                      18

                                       
          7.4  ACCOUNTANT'S LETTER.  The Representatives shall have received 
from Semple & Cooper a letter or letters dated, respectively, the date hereof 
and the Closing Date, in form and substance satisfactory to the 
Representatives, to the effect that:

               (a)    they are independent accountants with respect to the 
Company within the meaning of the Act and the Rules and Regulations;

               (b)    in their opinion, the financial statements audited by 
them and included in the Registration Statement and the Prospectus comply in 
form in all material respects with the applicable accounting requirements of 
the Act and the related published rules and regulations;

               (c)    on the basis of a reading of the audited financial 
statements of the Company, for the years ended June 30, 1995 and June 30, 
1996, and the unaudited financial statements of the Company for the period 
ended December 31, 1996, and the notes thereto, carrying out certain 
specified procedures (which do not constitute an audit made in accordance 
with generally accepted auditing standards) that would not necessarily reveal 
matters of significance with respect to the comments set forth in this 
paragraph, a reading of the minute books of the shareholders, the board of 
directors and any committees thereof of the Company, and inquiries of certain 
officials of the Company who have responsibility for financial and accounting 
matters, nothing came to their attention that caused them to believe that:

                      (i)  the unaudited condensed financial statements of 
the Company included in the Registration Statement and the Prospectus do not 
comply in form in all material respects with the applicable accounting 
requirements of the Act and the related published rules and regulations 
thereunder or are not in conformity with generally accepted accounting 
principles applied on a basis substantially consistent with that of the 
audited financial statements included in the Registration Statement and the 
Prospectus; and

                      (ii) at a specific date not more than five business 
days prior to the date of such letter, there were any changes in the capital 
stock or long-term debt of the Company or any decreases in net current assets 
or stockholders' equity of the Company, in each case compared with amounts 
shown on the December 31, 1996 balance sheet included in the Registration 
Statement and the Prospectus, or for the period from December 31, 1996 to 
such specified date there were any decreases, as compared with the 
corresponding period in the preceding year, in net sales, gross profit, 
selling, general and administrative expenses, employee plans and bonuses, 
income (loss) from operations, interest expenses, income (loss) before income 
taxes, provision (benefit) for income taxes, net income (loss) or net income 
(loss) per share of the Company, except in all instances for changes, 
decreases or increases set forth in such letter; and

               (d)    they have carried out certain specified procedures, not 
constituting an audit, with respect to certain amounts, percentages and 
financial information that are derived from the general accounting records of 
the Company and are included in the Registration Statement and 



                                      19

                                       
the Prospectus, and have compared such amounts, percentages and financial 
information with such records of the Company and with information derived 
from such records and have found them to be in agreement, excluding any 
questions of legal interpretation.

     In the event that the letters referred to above set forth any such 
changes, decreases or increases, it shall be a further condition to the 
obligations of the Underwriters that such letters shall be accompanied by a 
written explanation of the Company as to the significance thereof, unless the 
Representatives deems such explanation unnecessary, and such changes, 
decreases or increases do not, in the sole judgment of the Representatives, 
make it impractical or inadvisable to proceed with the purchase and delivery 
of the Shares as contemplated by the Registration Statement, as amended as of 
the date hereof.

     References to the Registration Statement and the Prospectus in this 
Section 7.4 with respect to either letter referred to above shall include any 
amendment or supplement thereto at the date of such letter.

          7.5  OFFICER'S CERTIFICATE.  The Representatives shall have 
received a certificate, dated the Firm Closing Date, of the president and the 
principal financial or accounting officer of the Company to the effect that:

               (a)    the representations and warranties of the Company in 
this Agreement are true and correct as if made on and as of the Firm Closing 
Date; the Registration Statement, as amended as of the Firm Closing Date, 
does not include any untrue statement of a material fact or omit to state any 
material fact necessary to make the statements therein not misleading, in 
light of the circumstances in which they were made and the Prospectus, as 
amended or supplemented as of the Firm Closing Date, does not include any 
untrue statement of a material fact or omit to state any material fact 
necessary in order to make the statements therein not misleading, in the 
light of the circumstances under which they were made; and the Company has in 
all material respects performed all covenants and agreements and satisfied 
all conditions on its part to be performed or satisfied at or prior to the 
Firm Closing Date;

               (b)    no stop order suspending the effectiveness of the 
Registration Statement or any amendment thereto has been issued, and no 
proceedings for that purpose have been instituted or threatened or, to the 
best of their knowledge, are contemplated by the Commission; and

               (c)    subsequent to the respective dates as of which 
information is given in the Registration Statement and the Prospectus, the 
Company has not sustained any material loss or interference with its business 
or properties from fire, flood, hurricane, accident or other calamity, 
whether or not covered by insurance, or from any labor dispute or any legal 
or governmental proceeding, and there has not been any material adverse 
change, or any development involving a prospective material adverse change, 
in the condition (financial or otherwise), business prospects, net worth or 
results of operations of the Company, except in each case as described in or 
contemplated by the Prospectus (exclusive of any amendment or supplement 
thereto).



                                      20


          7.6  NASD REVIEW.  The NASD, upon review of the terms of the public 
offering of the Firm Shares and Option Shares, shall not have objected to the 
Underwriters' participation in such offering.

          7.7  LOCKUPS.  The Representatives shall have received from each 
officer, director and person who owns more than five percent (5%) of the 
Company's Common Stock, or securities convertible into Common Stock, an 
agreement to the effect that such person will not, directly or indirectly, 
without the prior written consent of the Representatives, offer, sell or 
grant any option to purchase or otherwise dispose (or announce any offer, 
sale, grant of an option to purchase or other disposition) of any shares of 
Common Stock or any securities convertible into, or exchangeable for, shares 
of Common Stock for a period of  twelve months.

          7.8  DUE DILIGENCE EXAMINATION.  The counsel to the Representatives 
and other persons retained by the Representatives to conduct a due diligence 
investigation with respect to the offering, shall be reasonably satisfied 
with the results of their respective due diligence investigations.

          7.9  BLUE SKY QUALIFICATION.  The Shares shall be qualified in such 
states as the Representatives may reasonably request pursuant to Section 5.4, 
and each such qualification shall be in effect and not subject to any stop 
order or other proceeding on the Closing Date or Option Closing Date, as the 
case may be.

          7.10 OTHER DOCUMENTS.  On or before the Firm Closing Date, the 
Representatives and counsel for the Representatives shall have received such 
further certificates, documents or other information as they may have 
reasonably requested from the Company.

     All opinions, certificates, letters and documents delivered pursuant to 
this Agreement will comply with the provisions hereof only if they are 
reasonably satisfactory in all material respects to the Representatives.  The 
Company shall furnish to the Representatives such conformed copies of such 
opinions, certificates, letters and documents in such quantities as the 
Representatives and the counsel to the Representatives shall reasonably 
request.

     The respective obligations of the several Underwriters to purchase and 
pay for any Option Shares shall be subject, in the Representatives' 
discretion, to each of the foregoing conditions to purchase the Firm Shares, 
except that all references to the Firm Shares and the Firm Closing Date shall 
be deemed to refer to such Option Shares and the related Option Closing Date, 
respectively.

                                       
                                   SECTION 8.
                       INDEMNIFICATION AND CONTRIBUTION

          8.1  INDEMNIFICATION BY COMPANY.  The Company agrees to indemnify 
and hold harmless each Underwriter and each person, if any, who controls any 
Underwriter within the meaning of Section 15 of the Act or Section 20 of the 
Securities Exchange Act of 1934 (the 



                                      21

                                       
"Exchange Act") against any losses, claims, damages or liabilities, joint or 
several, to which such Underwriter or such controlling person may become 
subject under the Act, the Exchange Act or otherwise, insofar as such losses, 
claims, damages or liabilities (or actions in respect thereof) arise out of 
or are based upon:

               (a)    any untrue statement or alleged untrue statement made 
by the Company in Section 2 of this Agreement;

               (b)    any untrue statement or alleged untrue statement of any 
material fact contained in (i) the Registration Statement or any amendment 
thereto or any Preliminary Prospectus or the Prospectus or any amendment or 
supplement thereto, or (ii) any application or other document, or any 
amendment or supplement thereto, executed by the Company and based upon 
written information furnished by or on behalf of the Company filed in any 
jurisdiction in order to qualify the Shares under the securities or blue sky 
laws thereof or filed with the Commission or any securities association or 
securities exchange (each an "Application"); or

               (c)    the omission or alleged omission to state in the 
Registration Statement or any amendment thereto, any Preliminary Prospectus 
or the Prospectus or any amendment or supplement thereto, or any Application 
a material fact required to be stated therein or necessary to make the 
statements therein not misleading in light of the circumstances in which they 
are made, and will reimburse, as incurred, each Underwriter and each such 
controlling person for any legal or other expenses reasonably incurred by 
such Underwriter or such controlling person in connection with investigating, 
defending against or appearing as a third-party witness in connection with 
any such loss, claim, damage, liability or action; provided, however, that 
the Company will not be liable in any such case to the extent that any such 
loss, claim, damage or liability arises out of or is based upon any untrue 
statement or alleged untrue statement or omission or alleged omission made in 
such registration statement or any amendment thereto, any Preliminary 
Prospectus or the Prospectus or any amendment or supplement thereto, or any 
Application in reliance upon and in conformity with written information 
furnished to the Company by any Underwriter through the Representatives 
specifically for use therein; and provided further, that the Company will not 
be liable to any Underwriter or any person controlling such Underwriter with 
respect to any such untrue statement or omission made in any Preliminary 
Prospectus that is corrected in the Prospectus (or any amendment or 
supplement thereto) if the person asserting any such loss, claim, damage or 
liability purchased Shares from such Underwriter but was not sent or given a 
copy of the Prospectus (as amended or supplemented), other than the documents 
incorporated by reference therein at or prior to the written confirmation of 
the sale of such Shares to such person in any case where such delivery of the 
Prospectus (as amended or supplemented) is required by the Act, unless such 
failure to deliver the Prospectus (as amended or supplemented) was a result 
of noncompliance by the Company with Section 5.5 of this Agreement.  This 
indemnity agreement will be in addition to any liability which the Company 
may otherwise have.  The Company will not, without the prior written consent 
of each Underwriter, settle or compromise or consent to the entry of any 
judgment in any pending or threatened claim, action, suit or proceeding in 
respect of which indemnification may be sought hereunder (whether or not such 
Underwriter or any person who controls such Underwriter 


                                      22

                                       
within the meaning of Section 15 of the Act or Section 20 of the Exchange Act 
is a party to such claim, action, suit or proceeding), unless such 
settlement, compromise or consent includes an unconditional release of such 
Underwriter and each such controlling person from all liability arising out 
of such claim, action, suit or proceeding.

          8.2  INDEMNIFICATION BY UNDERWRITERS.  Each Underwriter will 
indemnify and hold harmless the Company, each of its directors, each of its 
officers who signed the Registration Statement and each person, if any, who 
controls the Company within the meaning of Section 15 of the Act or Section 
20 of the Exchange Act against any losses, claims, damages or liabilities to 
which the Company, any such director or officer of the Company or any such 
controlling person of the Company may become subject under the Act, the 
Exchange Act or otherwise, insofar as such losses, claims, damages or 
liabilities (or actions in respect thereof) arise out of or are based upon 
(a) any untrue statement or alleged untrue statement of any material fact 
contained in the Registration Statement or any amendment thereto, any 
Preliminary Prospectus or the Prospectus or any amendment or supplement 
thereto, or any Application or (b) the omission or the alleged omission to 
state therein a material fact required to be stated in the Registration 
Statement or any amendment thereto, any Preliminary Prospectus or the 
Prospectus or any amendment or supplement thereto, or any Application or 
necessary to make the statements therein not misleading in light of the 
circumstances in which they are made, in each case to the extent, but only to 
the extent, that such untrue statement or alleged untrue statement or 
omission or alleged omission was made in reliance upon and in conformity with 
written information furnished to the Company by any Underwriter through the 
Representatives specifically for use therein; and, subject to the limitation 
set forth immediately preceding this clause, will reimburse, as incurred, any 
legal or other expenses reasonably incurred by the Company or any director, 
officer or controlling person of the Company in connection with investigation 
or defending against or appearing as a third-party witness in connection with 
any such loss, claim, damage, liability or any action in respect thereof.  
This indemnity agreement will be in addition to any liability which such 
Underwriter may otherwise have.  No Underwriter will, without the prior 
written consent of the Company, settle or compromise or consent to the entry 
of any judgment in any pending or threatened claim, action, suit or 
proceeding in respect of which indemnification may be sought hereunder 
(whether or not the Company, any of its directors, any of its officers who 
signed the Registration Statement or any person who controls the Company 
within the meaning of Section 15 of the Act or Section 20 of the Exchange Act 
is a party to such claim, action, suit or proceeding), unless such 
settlement, compromise or consent includes an unconditional release of the 
Company and each such director, officer and controlling person from all 
liability arising out of such claim, action, suit or proceeding.

          8.3  NOTICE OF DEFENSE.  Promptly after receipt by an indemnified 
party under this Section 8 of notice of the commencement of any action, such 
indemnified party will, if a claim in respect thereof is to be made against 
the indemnifying party under this Section 8, notify the indemnifying party of 
the commencement thereof; but the omission so to notify the indemnifying 
party will not relieve it from any liability which it may have to any 
indemnified party otherwise than under this Section 8.  In case any such 
action is brought against any indemnified party, and it notifies the 
indemnifying party of the commencement thereof, the indemnifying party will 
be entitled to 



                                      23

                                       
participate therein and, to the extent that it may wish, jointly with any 
other indemnifying party and the indemnified party shall have reasonably 
concluded that there may be one or more legal defenses available to it and/or 
other indemnified parties which are different from or additional to those 
available to the indemnifying party, the indemnifying party shall not have 
the right to direct the defense of such action on behalf of such indemnified 
party or parties and such indemnified party or parties shall have the right 
to select separate counsel to defend such action on behalf of such 
indemnified party or parties.  After notice from the indemnifying party to 
such indemnified party of its election so to assume the defense thereof and 
approval by such indemnified party of counsel appointed to defend such 
action, the indemnifying party will not be liable to such indemnified party 
(which may not be unreasonably withheld or delayed) under this Section 8 for 
any legal or other expenses, other than reasonable costs of investigation, 
subsequently incurred by such indemnified party in connection with the 
defense thereof, unless (a) the indemnified party shall have employed 
separate counsel in accordance with the proviso to the next preceding 
sentence (it being understood, however, that in connection with such action 
the indemnifying party shall not be liable for the expenses of more than one 
separate counsel at any one time in any one action or separate but 
substantially similar actions in the same jurisdiction arising out of the 
same general allegations or circumstances, designated by the Representatives 
in the case of Section 8.1, representing the indemnified parties under such 
Section 8.1 who are parties to such action or actions) or (b) the 
indemnifying party has authorized the employment of counsel for the 
indemnified party at the expense of the indemnifying party.  After such 
notice from the indemnifying party to such indemnified party, the 
indemnifying party will not be liable for the costs and expenses of any 
settlement of such action effected by such indemnified party without the 
consent of the indemnifying party, unless such indemnified party waived its 
rights under this Section 8 in which case the indemnified party may effect 
such a settlement without such consent.

          8.4  CONTRIBUTION.  In circumstances in which the indemnity 
agreement provided for in the preceding paragraphs of this Section 8 is 
unavailable or insufficient to hold harmless an indemnified party in respect 
of any losses, claims, damages or liability (or actions in respect thereof), 
each indemnifying party, in order to provide for just and equitable 
contribution, shall contribute to the amount paid or payable by such 
indemnified party as a result of such losses, claims, damages or liabilities 
(or actions in respect thereof) in such proportion as is appropriate to 
reflect (a) the relative benefits received by the indemnifying party or 
parties on the one hand and the indemnified party on the other from the 
offering of the Shares or (b) if the allocation provided by the foregoing 
clause (a) is not permitted by applicable law, not only such relative 
benefits but also the relative fault of the indemnifying party or parties on 
the one hand and the indemnified party on the other in connection with the 
statements or omissions or alleged statements or omissions that resulted in 
such losses, claims, damages or liability (or action in respect thereof).  
The relative benefits received by the Company on the one hand and the 
Underwriters on the other shall be deemed to be in the same proportion as the 
total proceeds from the offering (after deducting expenses) received by the 
Company bear to the total underwriting discounts and commissions received by 
the Underwriters.  The relative fault of the parties shall be determined by 
reference to, among other things, whether the untrue or alleged untrue 
statement of a material fact or the omission or alleged omission to state a 
material fact relates to information supplied by the Company or the 
Underwriters, the parties' relative 



                                      24

                                       
intents, knowledge, access to information and opportunity to correct or 
prevent such statement or omission, and any other equitable considerations 
appropriate in the circumstances.  The Company and the Underwriters agree 
that it would not be equitable if the amount of such contribution were 
determined by pro rata or per capita allocation (even if the Underwriters 
were treated as one entity for such purpose) or by any other method of 
allocation that does not take into account the equitable consideration 
referred to in the first sentence of this Section 8.4.  Notwithstanding any 
other provision of this Section 8.4, no Underwriter shall be obligated to 
make contributions hereunder that in the aggregate exceed the underwriter 
discount on the Shares purchased by such Underwriter under this Agreement, 
less the aggregate amount of any damages that such Underwriter has otherwise 
been required to pay in respect of the same or any substantially similar 
claim, and no person guilty of fraudulent misrepresentation (within the 
meaning of Section 11(f) of the Act) shall be entitled to contribution from 
any person who was not guilty of such fraudulent misrepresentation.  The 
Underwriters' obligations to contribute hereunder are several in proportion 
to their respective underwriting obligations and not joint, and contributions 
among Underwriters shall be governed by the provisions of the Agreement Among 
Underwriters.  For purposes of this Section 8.4, each person, if any, who 
controls an Underwriter within the meaning of Section 15 of the Act or 
Section 20 of the Exchange Act shall have the same rights to contribution as 
such Underwriter, and each director of the Company, each officer of the 
Company who signed the Registration Statement and each person, if any, who 
controls the Company within the meaning of Section 15 of the Act or Section 
20 of the Exchange Act, shall have the same right to contribution as the 
Company as the case may be.

                                       
                                   SECTION 9.
                           DEFAULT OF UNDERWRITERS

     If one or more Underwriters default in their obligations to purchase 
Firm Shares, or Option Shares hereunder and the aggregate number of such 
Shares that such defaulting Underwriter or Underwriters agreed but failed to 
purchase is ten percent or less of the aggregate number of Firm Shares or 
Option Shares to be purchased by all of the Underwriters at such time 
hereunder, the other Underwriters may make arrangements satisfactory to the 
Representatives for the purchase of such Shares by other persons (who may 
include one or more of the non-defaulting Underwriters, including the 
Representatives), but if no such arrangements are made by the Firm Closing 
Date or the related Option Closing Date, as the case may be, the other 
Underwriters shall be obligated severally in proportion to their respective 
commitments hereunder to purchase the Firm Shares, or Option Shares that such 
defaulting Underwriter or Underwriters agreed but failed to purchase. In the 
event of any default by one or more Underwriters as described in this Section 
9, the Representatives shall have the right to postpone the Firm Closing Date 
or the Option Closing Date, as the case may be, established as provided in 
Section 3 hereof for not more than seven business days in order that any 
necessary changes may be made in the arrangements or documents for the 
purpose and delivery of the Firm Shares or Option Shares, as the case may be. 
As used in this Agreement, the term "Underwriter" includes any persons 
substituted for an Underwriter under this Section 9.  Nothing herein shall 
relieve any defaulting Underwriter from liability for its default.



                                      25

                                       
                                  SECTION 10.
                                   SURVIVAL

     The respective representations, warranties, agreements, covenants, 
indemnities and other statements of the Company, its officers and directors 
and the several Underwriters set forth in this Agreement or made by or on 
behalf of them, respectively, pursuant to this Agreement shall remain in full 
force and effect, regardless of (a) any investigation made by or on behalf of 
the Company, any of its officers or directors, any Underwriter or any 
controlling person referred to in Section 8 hereof and (b) delivery of and 
payment for the Shares.  The respective agreements, covenants, indemnities 
and other statements set forth in Sections 5 and 8 hereof shall remain in 
full force and effect, regardless of any termination or cancellation this 
Agreement.

                                       
                                  SECTION 11.
                                 TERMINATION

          11.1 BY REPRESENTATIVES.  This Agreement may be terminated with 
respect to the Firm Shares or any Option Shares in the sole discretion of the 
Representatives by notice to the Company given prior to the Firm Closing Date 
or the related Option Closing Date, respectively, in the event that the 
Company shall have failed, refused or been unable to perform all obligations 
and satisfy all conditions on its part to be performed or satisfied hereunder 
at or prior thereto or, if at or prior to the Firm Closing date or such 
Option Closing Date, respectively:

               (a)    the Company shall have sustained any material loss or 
interference with its business or properties from fire, flood, hurricane, 
accident or other calamity, whether or not covered by insurance, or from any 
labor dispute or any legal or governmental proceeding or there shall have 
been any material adverse change, or any development involving a prospective 
material adverse change (including financial or otherwise), in the business 
prospects, net worth or results of operations of the Company, except in each 
case as described in or contemplated by the Prospectus (exclusive of any 
amendment or supplement thereto);

               (b)    trading in the Common Stock shall have been suspended 
by the Commission or the National Association of Securities Dealers Automated 
Quotation SmallCap Market or trading in securities generally on the New York 
Stock Exchange or the American Stock Exchange shall have been suspended or 
minimum or maximum prices shall have been established on any such exchange or 
market system;

               (c)    a banking moratorium shall have been declared by New 
York, California, or United States authorities; or

               (d)    there shall have been (i) an outbreak or escalation of 
hostilities between the United States and any foreign power, (ii) an outbreak 
or escalation of any other insurrection or armed conflict involving the 
United States or (iii) any other calamity or crisis having an effect on the 
financial markets that, in the reasonable judgment of the Representatives, 
makes it 



                                      26

                                       
impracticable or inadvisable to proceed with the public offering or the 
delivery of the Shares as contemplated by the Registration Statement, as 
amended as of the date hereof.

          11.2 EFFECT OF TERMINATION HEREUNDER.  Termination of this 
Agreement pursuant to this Section 11 shall be without liability of any party 
to any other party, except as provided in Section 10 hereof.

                                       
                                  SECTION 12.
                    INFORMATION SUPPLIED BY UNDERWRITERS

     The statements set forth in the last paragraph on the front cover page 
and under the heading "Underwriting" in any Preliminary Prospectus or the 
Prospectus, to the extent such statements relate to the Underwriters 
constitute the only information furnished by any Underwriter through the 
Representatives to the Company for the purposes of Section 8 and 10 hereof.  
The Underwriters represent and warrant to the Company that such statements, 
to such extent, are correct as of the date hereof and at each Closing Date.

                                       
                                   SECTION 13.
                                    NOTICES

     All communications hereunder shall be in writing and, if sent to any of 
the Underwriters, shall be mailed (certified or registered mail, postage 
prepaid, return receipt requested) or delivered or sent by facsimile 
transmission and confirmed in writing to Spelman & Co., Inc., 2355 Northside 
Drive, Suite 200, San Diego, California 92108, Attention:  Mr. Jason Rogers 
(with a copy to Dennis J. Doucette, Esq., Luce, Forward, Hamilton & Scripps 
LLP, 600 West Broadway, Suite 2600, San Diego, CA  92101), if sent to the 
Company, shall be mailed (certified or registered mail, postage prepaid, 
return receipt requested), delivered or sent by facsimile transmission and 
confirmed in writing to the Company at 550 Monterey Highway, Morgan Hill, 
California 95037 Attention: Floyd Hill, CEO, (with a copy to Gary A. Agron, 
Esq., Law Offices of Gary A. Agron, 5445 DTC Parkway, Suite 520, Englewood, 
Colorado 80111).  Notices shall be effective if mailed, 48 hours after 
deposit in the mail properly addressed, sent by facsimile, upon receipt and 
in any other instance, when delivered.

                                       
                                  SECTION 14.
                                  SUCCESSORS

     This Agreement shall inure to the benefit of and shall be binding upon 
the several Underwriters, the Company and their respective successors and 
legal representatives, and nothing expressed or mentioned in this Agreement 
is intended or shall be construed to give any other person any legal or 
equitable right, remedy or claim under or in respect of this Agreement, or 
any provisions herein contained, this Agreement and all conditions and 
provisions hereof being intended to be and being for the sole and exclusive 
benefit of such persons and for the benefit of no other person except that 
(a) the indemnities of the Company contained in Section 8 of this Agreement 
shall also be for 



                                      27

                                       
the benefit of any person or persons who control any Underwriter within the 
meaning of Section 15 of the Act or Section 20 of the Exchange Act and (b) 
the indemnities of the Underwriters contained in Section 8 of this Agreement 
shall also be for the benefit of the directors of the Company, the officers 
of the Company who have signed the Registration Statement and any person or 
persons who control the Company within the meaning of Section 15 of the Act 
or Section 20 of the Exchange Act.  No purchaser of Shares from any 
Underwriter shall be deemed a successor because of such purchase.

                                       
                                  SECTION 15.
                                 APPLICABLE LAW

     The validity and interpretation of this Agreement, and the terms and 
conditions set forth herein, shall be governed by and construed in accordance 
with the laws of the State of California without giving effect to any 
provisions relating to conflicts of laws.

                                       
                                  SECTION 16.
                                 COUNTERPARTS

     This Agreement may be executed in two or more counterparts, each of 
which shall be deemed an original, but all of which together shall constitute 
one and the same instrument.

     If the foregoing correctly sets forth our understanding, please indicate 
your acceptance thereof in the space provided below for that purpose, 
whereupon this letter shall constitute an agreement binding the Company, and 
each of the several Underwriters.

                                            Very truly yours,

                                            ORGANIC FOOD PRODUCTS


                                            By:
                                               ------------------------------
                                               Floyd Hill
                                               Chief Executive Officer


The foregoing Agreement is hereby
confirmed and accepted as of the
date first above written.

Sentra Securities Corporation
Spelman & Co., Inc.
(As Representatives of the several 
  Underwriters named in Schedule 1 hereto)

By:
   ---------------------------------
     Richard P. Woltman, President



                                      28

                                       
                                  SCHEDULE 1

                                 UNDERWRITERS


                                                           Number of Firm Shares
Underwriter                                                   to be purchased
- -----------                                                ---------------------

Sentra Securities Corporation

Spelman & Co., Inc.









         Total
                                                           ---------------------